The Hong Kong Science & Technology Parks Corporation (HKSTP) is pushing at the frontiers in the advancement of innovative biomedical technologies that will benefit society and healthcare as we know it. 

Members got the opportunity to see firsthand some of the developments during a visit to HKSTP Experience Centre on 6 September. The facility featured their latest “art tech” project called “MAN-MADE,” which blends Chinese philosophy with modern technology. 

Members also heard some inspiring stories of how a number of small start-ups took off. Grace Lau, Head, Institute for Translational Research from HKSTP, explained how HKSTP is driving innovative biomedical technologies to improve healthcare services. Jimmy Tao, CEO of Vitargent (International) Biotechnology Limited, shared how the company developed toxicity tests using medaka and zebra fish embryos. 

Jenny Chiu, General Manager of PHASE Scientific, also shared her success in developing innovative solutions that target specific molecules, even when their fluid concentration levels are low. The breakthrough has been widely applied in COVID-19 PCR and Rapid Antigen Tests. To cap off the trip, members visited the laboratories to learn more about their award-winning technologies.